PateƱo, Elizabeth .
HRN: 06-60-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2023
LEVOFLOXACIN 500MG (TAB)
07/15/2023
07/21/2023
PO
750mg Tab
OD
Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes